DWTX logo

DWTX
Dogwood Therapeutics Inc.

6,916
Mkt Cap
$60.2M
Volume
32,646.00
52W High
$9.50
52W Low
$1.28
PE Ratio
-0.17
DWTX Fundamentals
Price
$1.79
Prev Close
$1.81
Open
$1.82
50D MA
$1.93
Beta
0.78
Avg. Volume
132,051.89
EPS (Annual)
-$7.14
P/B
0.74
Rev/Employee
$0.00
$14.34
Loading...
Loading...
News
all
press releases
Dogwood Therapeutics, Inc (NASDAQ:DWTX) Sees Large Increase in Short Interest
Dogwood Therapeutics, Inc (NASDAQ:DWTX - Get Free Report) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totaling 70,605 shares, a growth...
News Placeholder
More News
News Placeholder
Q1 Earnings Estimate for DWTX Issued By Zacks Research
Dogwood Therapeutics, Inc (NASDAQ:DWTX - Free Report) - Equities researchers at Zacks Research issued their Q1 2026 EPS estimates for Dogwood Therapeutics in a research note issued to investors on...
News Placeholder
Dogwood Therapeutics (DWTX) to Release Quarterly Earnings on Monday
Dogwood Therapeutics (NASDAQ:DWTX) will be releasing its Q4 2025 earnings before the market opens on Monday, March 30. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-30-dogwood-therapeutics-inc-stock...
News Placeholder
HC Wainwright Issues Positive Forecast for DWTX Earnings
Dogwood Therapeutics, Inc (NASDAQ:DWTX - Free Report) - Stock analysts at HC Wainwright raised their Q1 2026 EPS estimates for shares of Dogwood Therapeutics in a research report issued on Thursday, March 19th. HC Wainwright analyst S. Lee now expects that the company will post earnings per share of...
News Placeholder
What is HC Wainwright's Estimate for DWTX FY2030 Earnings?
Dogwood Therapeutics, Inc (NASDAQ:DWTX - Free Report) - Equities researchers at HC Wainwright issued their FY2030 earnings per share (EPS) estimates for shares of Dogwood Therapeutics in a research...
News Placeholder
Short Interest in Dogwood Therapeutics, Inc (NASDAQ:DWTX) Decreases By 15.1%
Dogwood Therapeutics, Inc (NASDAQ:DWTX - Get Free Report) saw a large decline in short interest in the month of February. As of February 27th, there was short interest totaling 56,171 shares, a...
News Placeholder
Dogwood Therapeutics (NASDAQ:DWTX) Shares Up 1.7% - Time to Buy?
Dogwood Therapeutics (NASDAQ:DWTX) Shares Up 1.7% - Time to Buy...
News Placeholder
What's Driving the Market Sentiment Around Dogwood Therapeutics Inc?
read more...
News Placeholder
DWTX Stock Heads For Worst Day In 9 Months As Chemotherapy Pain Drug Interim Study Data Fails To Boost Investor Confidence
The company said that Halneuron demonstrated separation from placebo treated patients in terms of pain improvement but did not detail the scale of the said improvement.
News Placeholder
Dogwood Therapeutics Stock Soars Pre-Market On Securing License For Cancer-Related Pain Management Drug
In return for the license, Sepin Pharma and its designated affiliates will get 7.31% of Dogwood’s common stock, on a fully diluted basis.
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available